Schizophrenia Trial, Recruiting NCT05389787 Sponsor: Northwell Health Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05389787
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 60 years old, of any gender
  • People who have been diagnosed with a schizophrenia spectrum disorder according to standard diagnostic guidelines (DSM-5)
  • People who are able to understand and agree to participate in the trial on their own behalf

Who may not be able to join:

  • People who have ever been diagnosed with any other major psychiatric condition (besides a schizophrenia spectrum disorder) under standard diagnostic guidelines (DSM-5)
  • People who have ever been diagnosed with ataxia or other conditions affecting the cerebellum (the part of the brain that helps control movement and balance)
  • People who have ever been diagnosed with intellectual disability, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, or any other condition involving the progressive loss of nerve function
  • People who currently have a general health condition or a condition affecting the brain or nervous system that could affect thinking or response to treatment
  • People who have had problems with substance misuse or dependence in the past six months
  • People who have a history of seizures
  • People who have received a brain stimulation treatment called TMS in the past three months, or a treatment called ECT in the past six months
  • People who are currently pregnant
  • People for whom an MRI scan would not be safe (for example, due to metal implants or other medical reasons) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northwell Health
Registry
ClinicalTrials.gov
Start date
18 August 2022
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cerebellar function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov